Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Abbott Laboratories (NY:ABT)

105.23 UNCHANGED

Streaming Delayed Price Updated: 7:00 PM EDT, Sep 9, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	362
Open	105.23
Bid (Size)	105.25 (100)
Ask (Size)	106.49 (100)
Prev. Close	105.23
Today's Range	105.23 - 105.23
52wk Range	81.97 - 137.49
Shares Outstanding	1,750,942,289
Dividend Yield	2.39%

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

If a Stock Market Crash Is Coming, Investors Will Want to Own This Dividend King ↗

September 08, 2026

Worried about a pullback? This Dividend King pairs a 54-year streak with catalysts that could provide income even if the market crashes.

Via The Motley Fool

Moderna Just Doubled Overnight, and 2 More Healthcare Stocks Could Follow It ↗

September 06, 2026

Moderna, Pharvaris and AbbVie span short, mid and long-term healthcare setups, from melanoma data to a Phase 3 catalyst and 13 straight years of dividend hikes.

Via MarketBeat

Performance

YTD	-15.3%	-15.3%
1 Month	-3.1%	-3.1%
3 Month	+18.0%	+18.0%
6 Month	-4.6%	-4.6%
1 Year	-20.3%	-20.3%

More News

3 Dividend Stocks to Buy and Hold Forever (Including 1 Dividend King) ↗

September 05, 2026

Via The Motley Fool

Abbott Laboratories (NYSE:ABT) Clears All Quality Investing Hurdles ↗

August 26, 2026

Via Chartmill

Abbott Laboratories (NYSE:ABT): A Strong Candidate for Quality Investors ↗

July 30, 2026

Via Chartmill

If the AI Boom Slows Down, History Says This Is the Smartest Way to Protect Your Long-Term Portfolio ↗

September 02, 2026

Via The Motley Fool

Just Starting Out With $5,000? 3 Magnificent ETFs to Buy in 2026. ↗

August 31, 2026

Via The Motley Fool

Billionaire Ken Griffin Increased His Stake in This Dividend King by 547% in Q2. Wall Street Thinks It's Still a Buy. ↗

August 26, 2026

Via The Motley Fool

Billionaire Ken Griffin Just Loaded Up on AbbVie and Abbott. Here's Whether Investors Should Follow His Lead. ↗

August 24, 2026

Via The Motley Fool

Better Dividend King to Buy Right Now: Abbott Labs or Johnson & Johnson? ↗

August 23, 2026

Via The Motley Fool

Recent Report Shows That Rep. Rick Allen Sold Up to $50K Worth of Abbott Laboratories Stock ↗

August 19, 2026

Via Benzinga

If You Invest $100 a Month in SCHD, Here's the Passive Income It Could Deliver in 20 Years ↗

August 17, 2026

Via The Motley Fool

Recent Report Shows That Rep. Richard Dean Dr McCormick Sold Up to $375K Worth of Abbott Laboratories Stock ↗

August 17, 2026

Via Benzinga

The L.A. Lakers Delivered a 1-Year Return of 25%. These ETFs Have Done Even Better. ↗

August 16, 2026

Via The Motley Fool

Recession-Proofing Your Portfolio Before the Storm Hits ↗

August 13, 2026

Via The Motley Fool

The U.S. Labor Market Is Weakening. These 2 Dividend Stocks Look Built to Weather a Recession ↗

August 11, 2026

Via The Motley Fool

AbbVie Piles on $8 Billion in Debt for Its Apogee Deal -- Should Dividend Investors Worry? ↗

August 11, 2026

Via The Motley Fool

AbbVie vs. Abbott Laboratories: Which Healthcare Stock Is a Better Buy in 2026? ↗

August 07, 2026

Via The Motley Fool

Solventum Nears Inflection Point As It Begins to Unlock Value ↗

August 07, 2026

Via MarketBeat

This Stock Keeps Raising Its Dividend No Matter What the Market Does -- and Wall Street Thinks It's a Buy Right Now ↗

August 05, 2026

Via The Motley Fool

Abbott Laboratories vs. Eli Lilly: Which Healthcare Stock Is a Better Buy in 2026? ↗

August 02, 2026

Via The Motley Fool

Abbott Laboratories vs. Johnson & Johnson: Which Healthcare Stock Is a Better Buy in 2026? ↗

July 31, 2026

Via The Motley Fool

3 Dividend Stocks to Buy for a Lifetime of Passive Income ↗

July 29, 2026

Via The Motley Fool

AbbVie Has Raised Its Dividend for 53 Straight Years and Still Looks Attractively Valued. Is This Dividend King the Smartest Buy in Healthcare Right Now? ↗

July 29, 2026

Via The Motley Fool

Why Wall Street Can't Get Enough of This Dividend King ↗

July 25, 2026

Via The Motley Fool

Frequently Asked Questions

Is Abbott Laboratories publicly traded?

Yes, Abbott Laboratories is publicly traded.

What exchange does Abbott Laboratories trade on?

Abbott Laboratories trades on the New York Stock Exchange

What is the ticker symbol for Abbott Laboratories?

The ticker symbol for Abbott Laboratories is ABT on the New York Stock Exchange

What is the current price of Abbott Laboratories?

The current price of Abbott Laboratories is 105.23

When was Abbott Laboratories last traded?

The last trade of Abbott Laboratories was at 09/09/26 07:00 PM ET

What is the market capitalization of Abbott Laboratories?

The market capitalization of Abbott Laboratories is 184.25B

How many shares of Abbott Laboratories are outstanding?

Abbott Laboratories has 184B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.